Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026)
Tyra Biosciences' Capital Expenditures came in at $66,000 for Q2 2026, up 112.9% from $31,000 a year earlier but down 25.0% from the prior quarter.
Powered by 
Analysis
Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tyra Biosciences reported Capital Expenditures of $250,000, up 142.7% year-over-year; for FY2025, it was $141,000, down 78.8% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $664,000 in FY2024 (-13.8%), $770,000 in FY2023 (+37.7%), $559,000 in FY2022 (-15.4%) and $661,000 in FY2021 (+111.9%).
- The five-year range for quarterly Capital Expenditures is $6,000 (Q4 2024) to $603,000 (Q4 2023).
- Year-over-year, Capital Expenditures has increased for three consecutive quarters, with growth averaging 143.4% over the last eight quarters.
- The fastest year-over-year change in Capital Expenditures over five years came in Q2 2024 (growth of 993.0%), and the weakest in Q4 2024 (a decline of 99.0%).
- Business Quant data shows TYRA's Capital Expenditures at $88,000 (Q1 2026), $57,000 (Q4 2025) and $39,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Tyra Biosciences | 1.36 Bn | 1.06 Bn | - | 66,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 470,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Dec 31, 2023 | 603,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 251,000.00 |
| Mar 31, 2022 | 239,000.00 |
| Dec 31, 2021 | 105,000.00 |
| Sep 30, 2021 | 256,000.00 |
API Access
Tyra Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TYRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TYRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TYRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();